Posted by Michael Wonder on 20 Dec 2025
Eli Lilly cuts price of diabetes, weight loss drugs in Canada
17 December 2025 - Eli Lilly is slashing the prices of its popular diabetes and weight loss drugs Mounjaro and Zepbound by 20% or more in Canada, the Globe and Mail reported on Wednesday, citing a note to pharmacies issued by the US based drug maker.
The Canadian list price of a four week supply of Mounjaro or Zepbound would be lowered to 300 Canadian dollars ($217) for 2.5 mg and 5 mg doses, the report said.
